return to news
  1. Upstox
    /
  2. News
    /
  3. Market News
    /
  4. IPO
    /
  5. Symbiotec Pharmalab IPO Day 4: Check subscription status, allotment date and steps

Market News

Symbiotec Pharmalab IPO Day 4: Check subscription status, allotment date and steps

Journalist Kamal Joshi, former Republic TV and latestly news editor, currently associated with Upstox as senior ipo writer.
By Kamal Joshi

2 min read | Updated on August 27, 2026, 09:28 IST

Google
SelectUpstoxas yourPreferred news source
Copy link
Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

The ₹1,757 crore Symbiotec Pharmalab IPO is a combination of a fresh issue of equity shares worth up to ₹150 crore and an offer for sale (OFS) amounting to ₹1,607 crore.

The Indore-based Symbiotec Pharmalab Ltd is an R&D-driven pharmaceutical and biotechnology firm. | Image: symbiotec.com

The Indore-based Symbiotec Pharmalab Ltd is an R&D-driven pharmaceutical and biotechnology firm. | Image: symbiotec.com

The initial public offering of pharma and biotech player Symbiotec Pharmalab Ltd will end on Thursday, August 27. The subscription details for Day 4 will be out post 10 am.

Open FREE Demat Account within minutes!
Join now

As of Day 3, the issue was subscribed 5.30 times. It received bids for 6,96,21,390 shares compared to 1,31,24,929 shares on offer, as per the data available on the NSE website.

The quota for non-institutional investors (NIIs) was subscribed 12.18 times, while the portion for retail individual investors (RIIs) received 5.05 times subscription. The part for qualified institutional buyers (QIBs) attracted 59% subscription.

The ₹1,757 crore IPO is a combination of a fresh issue of equity shares worth up to ₹150 crore and an offer for sale (OFS) amounting to ₹1,607 crore by promoter Satwani Holdings LLP and investors India Business Excellence Fund III and Rosewood Investments.

Proceeds of the fresh issue will be utilised for debt clearance and corporate general purposes.

The Indore-based Symbiotec Pharmalab Ltd is an R&D-driven pharmaceutical and biotechnology firm with capabilities across three platforms -- biotechnology, organic chemistry and complex injectables.

It is a global leader in corticosteroid and steroidal-hormone active pharmaceutical ingredients (APIs).

Symbiotec Pharmalab IPO: Allotment and listing date

The allotment of Skyways Air Services is expected to be finalised on Friday, August 28, 2026. The company's equity shares will debut on both the NSE and the BSE on September 1.

Hy-Tech Engineers IPO Day 4: Check subscription status, allotment date and steps

How to check Symbiotec Pharmalab IPO allotment status on NSE

Steps to check Symbiotec Pharmalab IPO allotment status on MUFG Intime India

  • Head to MUFG Intime India's allotment status portal: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
  • Select ‘Symbiotec Pharmalab Limited’ from the drop-down list for issue names
  • Enter either your PAN, Application No, DP/Client ID, or Account No/IFSC
  • Press the ‘Submit’ button
Disclaimer: This article is written purely for informational purposes and should not be considered investment advice from Upstox. Securities mentioned are illustrative and not recommendations. Please consult a financial advisor before making any investment decisions.

About The Author

Journalist Kamal Joshi, former Republic TV and latestly news editor, currently associated with Upstox as senior ipo writer.
Kamal Joshi is a business journalist who covers markets and IPOs. He places a special focus on in-depth analysis of DRHPs, RHPs and public-issue documents to produce data-driven stories. He covers trends across mainboard and SME IPOs, anchor allocations, subscription status and post-listing performance. He is passionate about breaking news and enjoys playing pickleball, especially flexing his net play. He was previously associated with Republic TV and LatestLY.

Next Story